Celgene logo Celgene Logo
Search

  • United States
    • Australia
      • English
    • Austria
      • Deutsch
    • Belgium
      • Français
      • Nederlands
    • Brazil
      • Português
    • Canada
      • English
      • Français
    • China
      • 简体中文
    • Czech Republic
      • Čeština
    • Denmark
      • Dansk
    • Europe
      • English
    • Finland
      • Suomi
    • France
      • Français
    • Germany
      • Deutsch
    • Hungary
      • Magyar
    • Ireland
      • English
    • Italy
      • Italiano
    • Japan
      • 日本語
    • Luxembourg
      • Français
      • Nederlands
    • Malaysia
      • English
    • Mexico
      • Español
    • Netherlands
      • Nederlands
    • Norway
      • Norsk
    • Poland
      • Polski
    • Portugal
      • Português
    • Russia
      • Русский язык
    • Singapore
      • English
    • Slovakia
      • Slovenčina
    • Slovenia
      • Slovenčina
    • South Korea
      • 한국어
    • Spain
      • Español
    • Sweden
      • Svenska
    • Switzerland
      • Deutsch
    • Taiwan
      • 繁體中文
    • Thailand
      • English
    • Turkey
      • Türk
    • United Kingdom
      • English
    • United States
      • English
  • About
    • Our Story
    • Awards & Recognition
    • History
    • Our Culture
    • Our Employees
    • Leadership
      • Senior Management
      • Board of Directors and Committees
    • Compliance
      • Code of Business Conduct and Ethics
      • Sunshine Act FAQ
      • California Declaration of Compliance
      • Vermont Prescriber Information
      • Authorized Distributor of Record Listing
      • General Conformity Certifications for Celgene Products
    • Diversity
    • Global Office Network
      • Celgene Americas
      • Celgene EMEA
      • Celgene Asia Pacific
  • Diseases
    • Multiple Myeloma
    • Multiple Sclerosis
    • Psoriasis and Psoriatic Arthritis
  • Therapies
    • Anti-counterfeiting
  • Research & Development
    • Pipeline
    • Medical Innovation
      • IMiDs
      • Anti-inflammatory Compounds
    • R&D Locations
      • CITRE
      • Drug Discovery & Alliance Development
    • Clinical Trials
      • Celgene-sponsored Trials
      • Investigator-initiated Trials
      • Clinical Trials Data Sharing
    • Celgene Medical Affairs
      • Educational Grant Requests
        • Areas of Focus
        • Grant Application Requirements
        • Budget Guidelines
        • Grant Application Deadlines
        • Request for Proposal
        • Change of Scope
        • Budget Reconciliation & Evaluation Outcomes
        • Help Resources
      • Celgene Medical Information
        • Medical Information Request Form
    • Research Oncology
  • Responsibility
    • Patients First
      • Patient Safety, Support & Advocacy
        • Patient Safety
        • Innovation Impact Awards
        • Celgene Support for European Patient Organizations
        • EFPIA Spend Transparency Disclosure
      • Access to Treatment
        • Pricing Principles
    • Global Health
      • Access Accelerated
      • Celgene Cancer Care Links™
      • AMPATH: Building Healthcare Capacity For Patients in Africa
      • Neglected Tropical Diseases
      • R&D for Neglected Tropical Diseases
    • Employees & Community
      • Employees
        • Our Culture and Values
        • Employee Safety
        • Employee Wellness
        • Diversity and Inclusion
      • Celgene Community Initiatives
    • Environment
      • 2020 Environmental Goals
      • Environmental Management
        • Building Sustainably
        • CDP (Carbon Disclosure Project)
    • Business with Integrity
      • Governance
        • Sustainability & CR Governance
      • Ethics & Business Conduct
        • Reportable Allegations
        • Filing an Online Report
        • Country Access Codes
      • Public Policy
        • Association Memberships
      • Supply Chain
      • Celgene and the Sustainable Development Goals
    • Funding
      • Healthcare Related Donations
      • Charitable & Philanthropic Donations
      • Sponsorships
      • Corporate Memberships
      • Exhibits
      • Funding FAQs
      • Funding Contact Us
      • Medical Education Grants
  • Newsroom
    • Media Contacts
    • Multimedia Library
    • Press Releases
    • Cellular Immunotherapies
  • Patients
    • Celgene Patient Support®
    • Online Patient Resources
    • REMS – Pharmacy Network
    • Glossary
  • Medical Professionals
    • Celgene Medical Information
  • Partnerships
    • Business Development Partnerships
    • Advocacy Partnerships
    • Suppliers
  • Investors
  • Careers
    • CAR T Therapies
  • Contact Us
  • Home Page
  • Newsroom
  • Press Releases
  • Celgene Notified of ANDA Filing for POMALYST®
Font Size Smaller Font Size Larger Font Size

Celgene Notified of ANDA Filing for POMALYST®

April 3, 2017

  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google Plus
  • Share on Pinterest
  • Print
  • Share via Email
Celgene Notified of ANDA Filing for POMALYST®
  • Newsroom
    • Media Contacts
    • Multimedia Library
    • Press Releases
    • Cellular Immunotherapies

Search Newsroom

Media Requests

If you are a member of the press, please submit a question to our Corporate Affairs team here.

Submit a Media Inquiry

Press Releases

See all press releases 

Stay up to date

Sign up to receive the latest news and information from Celgene.

Sign Up


Twitter Feed

Tweets by @Celgene

Sign Up


Most Read

  • The Search Continues for More Multiple Sclerosis Treatment Options

  • Talking with Your Kids about Your Breast Cancer Diagnosis

  • Myeloma: from Deadly to Chronic


Follow Celgene

  • Celgene on Facebook
  • Celgene on Twitter
  • Celgene on LinkedIn
  • Celgene on Google Plus
  • Celgene on YouTube
  • Celgene on Pinterest

About Celgene

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.

Global Network

world map

HAVE A QUESTION OR CONCERN?
CONTACT US

  • Site Map
  • About
  • Therapies
  • Research & Development
  • Research Oncology
  • Responsibility
  • Newsroom
  • Pipeline
  • Value of Medical Innovation
  • Patients
  • Medical Professionals
  • Partnerships
  • Investors
  • Careers
  • Copyright © 2018 Celgene Corporation
  • Privacy Policy
  • Terms of Use
  • Newsroom
    • Media Contacts
    • Multimedia Library
    • Press Releases
    • Cellular Immunotherapies
X

You are now leaving www.CELGENE.com, a website provided by Celgene. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Celgene does not endorse and/or influence the content found on websites not owned/operated by Celgene.

Continue
To view Website
Cancel
To return to www.Celgene.com

These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the Global Network).

Continue
To view Website
Cancel
To return to www.Celgene.com
X

Beware of fraudulent and misleading emails being sent by unauthorized persons for job interviews/offers at Celgene Corporation. These messages are being sent to cheat individuals. Celgene never requires any payment to be made by any candidate to Celgene or to any individual or agency as part of our recruitment process. Celgene will never ask for bank account or credit card information pre-hire. Please report any such activity to Frank Marrero.

For authentic information about Celgene’s hiring, please visit Celgene’s official careers website.

Continue to Careers

Go to Celgene.com
X

The CSR synopses posting is for informational purposes only and is not intended to have any legally binding effect.

Continue Go Back